Expanding the Business Scope Through Adjacent and New Businesses
First written in FY2019. 10 of 13 entries say "Advanced", first in FY2020. Latest entry: 2026-09-28.
1 other company's latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Going forward, we will provide management support to a broad range of medical institutions, including general hospitals and referral hospitals, without limiting our focus to regional and depopulated areas.」
The company has reaffirmed its policy of expanding the scope of its peripheral and new businesses beyond regional and depopulated areas to a broad range of medical institutions, including general hospitals and secondary referral hospitals. - FY2024RaisedAnnual report
「Going forward, the company will provide management support to a broad range of medical institutions, including general hospitals and secondary referral hospitals, without limiting its scope to regional and depopulated areas.」
The company has indicated a policy of expanding the scope of its peripheral businesses beyond regional and depopulated areas to a broad range of medical institutions, including general hospitals and secondary referral hospitals. - FY2024-Q1AdvancedAnnual report
「In October 2023, the company began providing management support to 2 medical corporations in the same regional city. It intends to expand into peripheral businesses, including comprehensive support for medical institutions in remote areas that are considered structurally difficult to manage, by leveraging the expertise it has acquired through operating Ishinkan facilities and other activities.」
As a specific development of its peripheral and new businesses, the company has begun providing management support to 2 medical corporations in the same regional city and intends to expand into areas including comprehensive support for medical institutions in remote areas. - FY2022RestatedAnnual report
「The company is working to diversify its business portfolio through 株式会社明日の医療 and is focusing on measures to avoid excessive exposure to the effects of specific operating environments.」
The company has reaffirmed its policy of providing support for medical institutions and nursing-care facilities through 明日の医療 and diversifying its business portfolio. - FY2021AdvancedAnnual report
「The company is working to diversify its business portfolio through 株式会社明日の医療 and is focusing on measures to avoid excessive exposure to the effects of specific operating environments.」
The company has specified the expansion of peripheral and new businesses as a policy of providing support for medical institutions and nursing-care facilities through 明日の医療 and diversifying its business portfolio. - FY2020AdvancedAnnual report
「The company secures operating funds for medical institutions and nursing-care facilities through services such as early payment of medical and long-term care reimbursement receivables (factoring). It then advises on measures needed to improve hospital management, including the formation of a community healthcare platform, conversion of hospital wards, and organization-building for healthcare professionals, drawing on the network with medical institutions and other organizations developed over many years through the Ishinkan business.」
As a specific development of its peripheral and new businesses, the company has outlined support for medical institutions and nursing-care facilities through 株式会社明日の医療, including consulting and factoring. - FY2019First statedAnnual report
「In addition to the Ishinkan business, the company will develop necessary peripheral and new businesses.」
The company has identified expansion beyond the Ishinkan business as a means of maintaining its competitive advantage and becoming a leading company.